Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Plc Regulatory News (HAYD)

Share Price Information for Haydale Plc (HAYD)

Share Price is delayed by 15 minutes
Get Live Data
0.32    -0.005 (-1.54%)
Bid:
0.31
Ask:
0.33
Spread: 0.02 (6.452%)
Market Cap: £24.88m
HAYD Live PriceLast checked at - London Stock Exchange

Intraday Haydale Plc Share Chart

Functionalised Masterbatch Used in Bolflex Sole

9 Feb 2021 07:00

RNS Number : 4333O
Haydale Graphene Industries PLC
09 February 2021
 

 

REACH

 

For immediate release

09 February 2021

 

 

Haydale Graphene Industries plc

 

('Haydale' or the 'Group')

 

Haydale's Functionalised Nano-Enhanced Rubber Masterbatch Used in Bolflex Rubber Sole

 

Haydale, (AIM: HAYD), the global advanced materials group, is pleased to announce that Bolflex has purchased 80 kg of its functionalised nano-enhanced rubber masterbatch for use in its premium soles range for shoe production. This follows Haydale recently increasing the elastomer capability of its functionalised nano-enhanced rubber masterbatch.

Haydales' products are incorporated into the styrene-butadiene rubber (SBR) compound offering increased tear strength, abrasion resistance, flex resistance, slip resistance and coefficient of friction - all essential properties for footwear.

The initial order of 80 kg enabled Bolflex, to prepare 3,000 pairs of functionalised nano-enhanced rubber soles and Bolflex are currently evaluating the performance of their nano-enhanced shoe sole product against their competitor's products. Initial results are demonstrating improvements against its footwear specific test standards. The Group expects to receive follow up orders during 2021.

According to Lucintel, the global footwear sole material market is expected to reach $21.0 billion by 2023. Bolflex is a market leading company, specialising in the production and supply of soles for the European footwear industry. It is now one of the largest manufacturers of the Iberian Peninsula and Europe with an existing capacity to manufacture around 20,000 pairs a day.

Pedro Saraiva, Head of Sales at Bolflex, said: "We have evaluated a number of nanomaterial products prior to purchasing Haydale's product and noted a dramatic step-change improvement as a direct result of the proprietary functionalisation process. This has shown improvements in the handling, dispersion and overall performance of the nanomaterials when mixed into rubber compounds."

Keith Broadbent, Haydale CEO, said: "We are really pleased to be working with Bolflex on this product and look forward to seeing the Haydale logo on the soles of shoes produced."

 

 

- Ends -

 

 

 

 

For further information:

Haydale Graphene Industries plc

 

Keith Broadbent, CEO

Tel: +44 (0) 1269 842 946

Gemma Smith, Global Head of Marketing

 

 

Arden Partners plc (Nominated Adviser & Broker)

 

Ruari McGirr / Paul Shackleton / Ben Cryer

Tel: +44 (0) 20 7614 5900

 

Notes to Editors

Haydale is a global technologies and materials group that facilitates the integration of graphene and other nanomaterials into the next generation of commercial technologies and industrial materials. With expertise in graphene, silicon carbide and other nanomaterials, Haydale is able to deliver improvements in electrical, thermal and mechanical properties, as well as toughness through its state-of-the-art functionalisation. Haydale has granted patents for its technologies in Europe, USA, Australia, Japan and China and operates from six sites in the UK, USA and the Far East.

For more information please visit: www.haydale.com 

Twitter: @haydalegraphene 

 

About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRADZGGZVLLGMZG
Date   Source Headline
11th Jan 20222:14 pmRNSResult of AGM
11th Jan 20227:00 amRNSGNPs Enhance Clothing for iCraft and Pro-Specs
10th Jan 20227:00 amRNSChange of Adviser
24th Dec 202112:41 pmRNSSecond Price Monitoring Extn
24th Dec 202112:35 pmRNSPrice Monitoring Extension
17th Dec 20217:00 amRNSPosting of Annual Report and Notice of AGM
15th Dec 20217:16 amRNSFinal Results
10th Dec 20214:41 pmRNSSecond Price Monitoring Extn
10th Dec 20214:36 pmRNSPrice Monitoring Extension
10th Dec 20212:06 pmRNSSecond Price Monitoring Extn
10th Dec 20212:00 pmRNSPrice Monitoring Extension
5th Nov 20217:00 amRNSDate of Results
26th Oct 20219:05 amRNSSecond Price Monitoring Extn
26th Oct 20219:00 amRNSPrice Monitoring Extension
18th Oct 20217:00 amRNSNotice of Results
20th Sep 202111:49 amRNSResult of Oversubscribed Fundraising
20th Sep 20217:01 amRNSPrimaryBid Offer
20th Sep 20217:00 amRNSProposed Placing and Subscription
1st Sep 20217:00 amRNSUS Small Business Administration Loan Agreement
19th Aug 20217:00 amRNSHigh Performance Garments – Used in Tokyo
16th Aug 20217:51 amRNSFiling of Joint Patent with Airbus
2nd Aug 20217:00 amRNSIssue of Warrants
12th Jul 20217:00 amRNSCollaboration agreement with ProMake Limited
28th May 20212:05 pmRNSSecond Price Monitoring Extn
28th May 20212:01 pmRNSPrice Monitoring Extension
26th Apr 20217:00 amRNSExtension to CeramycGuard Distributor Agreement
6th Apr 20217:00 amRNSFeasibility Study Award
29th Mar 20217:00 amRNS401 Tech Bridge Partners with Haydale
26th Mar 202111:11 amRNS£1.1 million Innovate UK Loan Agreement
25th Mar 20212:00 pmRNSPrice Monitoring Extension
1st Mar 20217:00 amRNSBiwater Trial CeramycShield™ Treatment
26th Feb 20214:40 pmRNSSecond Price Monitoring Extn
26th Feb 20214:35 pmRNSPrice Monitoring Extension
24th Feb 20217:00 amRNSInterim Results
9th Feb 20217:00 amRNSFunctionalised Masterbatch Used in Bolflex Sole
5th Feb 20214:41 pmRNSSecond Price Monitoring Extn
5th Feb 20214:35 pmRNSPrice Monitoring Extension
28th Jan 20217:00 amRNSSales Representation Agreement and Trading Update
18th Jan 20219:00 amRNSPrice Monitoring Extension
30th Dec 20204:41 pmRNSSecond Price Monitoring Extn
30th Dec 20204:35 pmRNSPrice Monitoring Extension
15th Dec 20209:05 amRNSSecond Price Monitoring Extn
15th Dec 20209:00 amRNSPrice Monitoring Extension
8th Dec 202012:09 pmRNSResult of AGM
7th Dec 202012:30 pmRNSDistributor Agreement for iCraft PPE Mask
27th Nov 20207:00 amRNSFunctionalised Graphene Antibacterial Masks
18th Nov 20204:40 pmRNSSecond Price Monitoring Extn
18th Nov 20204:35 pmRNSPrice Monitoring Extension
10th Nov 20207:00 amRNSNotice of Annual General Meeting
30th Oct 20207:00 amRNSFull Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.